Comparative analysis of prophylactic intramuscular 15 PGF2? 125 ?g V/s intravascular methylergometrine for prevention of atonic post-partum haemorrhage (PPH) in high risk cases.

Authors

  • Deepika Verma Associate Professor Department of Obstetrics and Gynaecology Sri Aurobindo Medical College and PG Institute Indore
  • Ratnamala Thakur Department of Obstetrics and Gynaecology Sri Aurobindo Medical College and PG Institute Indore
  • Sunita Mishra Department of Obstetrics and Gynaecology Sri Aurobindo Medical College and PG Institute Indore
  • Abhyuday Verma Department of Obstetrics and Gynaecology Sri Aurobindo Medical College and PG Institute Indore
  • Pooja Bansal Department of Obstetrics and Gynaecology Sri Aurobindo Medical College and PG Institute Indore

DOI:

https://doi.org/10.7439/ijbar.v7i6.3344

Abstract

Objectives : To assess, evaluate and compare the safety and efficacy of intramuscular 15 PGF2? 125 ?g and intravenous 0.2mg methylergometrine during active management of third stage of labour in high risk women who are prone to develop atonic postpartum haemorrhage. Methods : 150 women at high risk factors of developing atonic PPH were divided into two groups. Group A received methylergometrine 0.2 mg intravenously and group B received 125mg PGF2a intramuscularly at the time of delivery of anterior shoulder prophylactically. Duration of third stage of labour, amount of blood loss, side effects of drugs used and complications, if any were noted and analyzed. Results : Amount of blood loss was more in group A as compared to group B. Diarrhoea was seen in 3 cases in prostaglandin group, none in methylergometrine group. Nausea, vomiting were seen in 2 women in each group. Conclusions : Prophylactic intramuscular 15 PGF2? 125 ?g is a better alternative to prophylactic intravenous methylergometrine 0.2 mg in high risk women who are more prone to develop atonic PPH.

Downloads

Download data is not yet available.

References

Eastman N.J williams obstetrics ed. 10, New York 1950, Appleton century- crofts company, INC, P-912.

Duthie SJ. Postpartum haemorrhage & cesserian section. Obst Gynaecol 1992; 99:364-67.

M.D Research Director, AP. Department of EM Mount Sinai Medical Centre up-date Jan 29. 2001.

Purushottam BJ, Roopa P. Prophylactic intramuscular PGF2? versus intravenous methyl ergometrine for prevention of atonic PPH in high risk women. J Obs Gynecol India. 2008;58(5):417

Waters EG. Surgical Management of Postpartum Haemorrhage with particular reference to ligation of uterine arteries. Am J Obstet. Gynecol 1952; 64:1143-48.

Combs CA Murphy El Laros Rk Jr. Factors associated with haemorrhage in caesarean delivery. Obstet Gynacol 1991;77: 77-82.

Mustafa G, Firdous N, Taing S, Manzoor, Khalida. Comparative Study of Prostaglandin F2 ? Versus Ergometrine in the Management of Post Partum Haemorrhage. JK Sci J Med Educ Res. 2007;9(1):30

Comls CA Murphy EL Laros RK Jr. factors associated with haemorrhage with vaginal delivery. Obstet Gynacol 1991; 77: 69-76.

Lalitha A. Prostaglandin in intractable postpartum haemorrhage. J Obst Gynaecol 1988; 39: 208-11.

Amit P, Sandeep M, Shaan D, Shirish D. Active management of IIIrd stage of labour with carbaprost. J Obst and Gynae Ind 1993 ; 734-37.

Anjaneyulu R, Devi PK, Jain S, et al. Prophylactic use of 15 (5) methyl PGF2? by IM route- A controlled clinical trial. Acta Obstet Gynecol Scand Suppl 1988;145:9-11.

Reddy R, Shenoy JS. Active management of third stage of labour: a comparative study in high risk patients for atonic PPH. J Obstet Gynecol India 2001;51:44-7.

Bhattacharya P, Devi PK, Jain S. Prophylactic use of 15 (S) 15 methyl PGE2? by intramuscular route for control of post partum bleeding - A comparative trial with methylergometrine. Acta Obstet Gynecol Scand Suppl 1988;145:13-5.

Downloads

Published

2016-06-30

Issue

Section

Original Research Articles

How to Cite

Comparative analysis of prophylactic intramuscular 15 PGF2? 125 ?g V/s intravascular methylergometrine for prevention of atonic post-partum haemorrhage (PPH) in high risk cases. (2016). International Journal of Biomedical and Advance Research, 7(6), 265-266. https://doi.org/10.7439/ijbar.v7i6.3344